Expert Opinion on the Role of Sacubitril/Valsartan in the Management of Hypertension in India by Uday M. Jadhav, Saumitra Ray, T. Govindan Unni, J. P. S. Sawhney, Ashwani Mehta, Shantanu Guha, Rajiv D. Karnik, Bhupen N. Desai, Aziz Khan, Keyur Patel, Jayesh S. Prajapati, Hitesh J. Shah, Rama Krishna Reddy, Sanjeev Kumar, Soumya Kanti Dutta, Saujatya Chakraborty, Ashfaque Ahmed, Ravi Vishnu Prasad, Gaurav Chaudhary, Amit Kumar, M. Manjappa, Sujal Shetty, Praveen Raja, Vimalraj Bogana Shanmugam

Subjects: “…Sacubitril/valsartan…”
Get full text

ANTIHYPERTENSIVE EFFICACY OF VALSARTAN IN SMOKERS VERSUS NON-SMOKERS WITH ARTERIAL HYPERTENSION: THE FIRST RESULTS OF RUSSIAN MULTICENTER OPEN STUDY by V. I. Podzolkov, V. A. Bulatov, A. V. Vigdorchik

Subjects: Get full text

ANTIHYPERTENSIVE EFFICACY AND INFLUENCE ON SEXUAL FUNCTION OF VALSARTAN AND VALSARTAN AND HYDROCHLOROTHIAZIDE COMBINATION IN SMOKERS VERSUS NON-SMOKERS WITH ARTERIAL HYPERTENSION by V. I. Podzolkov, A. V. Vigdorchik

Subjects: Get full text

DISSOLUTION PROFILE STUDIES OF BCS CLASS II DRUG VALSARTAN BY BIOWAIVER PROCEDURE by E. R. Brigas, E. V. Uspenskaya, V. V. Pisarev

Subjects: Get full text

VALSARTAN IN EVERYDAY CLINICAL PRACTICE IN RUSSIA: ANTIHYPERTENSIVE EFFICACY AND INFLUENCE ON SEXUAL FUNCTION IN PATIENTS WITH ARTERIAL HYPERTENSION by V. I. Podzolkov, V. A. Bulatov, A. V. Vigdorchik

Subjects: Get full text

Clinical study on leflunomide combined with valsartan in the treatment of diabetic nephropathy proteinuria by WANG Li, ZHANG Jia-gang, LI Yu-ying

Subjects: Get full text

Pharmacokinetics and Bioequivalence of Two Fixed-Dose Combination Tablets of Valsartan/Amlodipine (80/5 Mg) in Healthy Chinese Subjects by Tian M, Huang J, Chen Y, Jin Q, Jiang H, Shi C, Mei J, Xu M, Yu X, Yang S

Subjects: “…valsartan…”
Get full text

Interaction between dipeptidyl-peptidase-4 inhibitors and drugs acting on renin angiotensin aldosterone system for the risk of angioedema: a pharmacovigilance assessment using disp... by Kannan Sridharan, Gowri Sivaramakrishnan

Subjects: Get full text

A real-world pharmacovigilance analysis of potential ototoxicity associated with sacubitril/valsartan based on FDA Adverse Event Reporting System (FAERS) by Ning Wang, Haijun Wang, Ying Chen, Yanfeng Wang

Subjects: Get full text

Valsartan effects on platelet activity in patients with arterial hypertension and metabolic syndrom by I. N. Medvedev, T. A. Kumova

Subjects: Get full text

Baseline left ventricular ejection fraction predicts the magnitude of improvement in patients taking sacubitril/valsartan by José-Manuel Rubio-Campal, Carlos Rodriguez Lopez, Carla Lázaro Rivera, Francisco de Asís Díaz Cortegana, Loreto Bravo Calero, Cristina Aguilera Agudo, José María Romero-Otero, José Tuñón Fernández

Subjects: Get full text

Integrating Metabolomics, Histopathology, and Cardiac Marker Analysis to Assess Valsartan’s Efficacy in Mitigating Dasatinib-Induced Cardiac Toxicity in Sprague-Dawley Rats by Alhazzani K, Mohammed H, Algahtani MM, Aljerian K, Alhoshani A, As Sobeai HM, Ahamad SR, Alotaibi MR, Alhamed AS, Alasmari F, Alqinyah M, Alhamami HN, Alanazi AZ

Subjects: Get full text

COMBINATION OF DIRECT RENNIN INHIBITOR - ALISKIREN, ANGIOTENSIN II RECEPTOR BLOCKER - VALSARTAN, AND CALCIUM CHANNEL BLOCKER - AMLODIPINE, IN THERAPY OF HYPERTENSIVE PATIENT WITH G... by O. V. Dralova, M. L. Maksimov

Subjects: Get full text

Comparison of platelet hemostasis effects for angiotensin receptor blockers in patients with arterial hypertension and metabolic syndrome by I. N. Medvedev, T. A. Kumova

Subjects: Get full text

A Comparison Study of Olmesartan and Valsartan Effects on Myocardial Metabolism in Patients With Dilated Cardiomyopathy: the OVOID Trial by Sangyong Jo, Kyungil Park, Jae Hyuk Choi, Chang‐Bae Sohn, Jeonghwan Kim, Yong‐Seop Kwon, Su Hong Kim, Tae‐ho Park

Subjects: Get full text

Clinical Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction and With Reduced Ejection Fraction According to the Prognostic Nutritional Ind... by Simone Solano, Mingming Yang, Paolo Tolomeo, Toru Kondo, Li Shen, Pardeep S. Jhund, Inder S. Anand, Akshay S. Desai, Carolyn S. P. Lam, Aldo P. Maggioni, Felipe A. Martinez, Jean L. Rouleau, Muthiah Vaduganathan, Dirk J. van Veldhuisen, Faiez Zannad, Michael R. Zile, Milton Packer, Scott D. Solomon, John J. V. McMurray

Subjects: Get full text

OPEN-LABEL RANDOMIZED CROSS-SECTIONAL STUDY OF CLINICAL EQUIVALENCE OF GENERIC AND ORIGINAL VALSARTAN IN PATIENTS WITH ARTERIAL HYPERTENSION by V. B. Mychka, A. L. Vertkin, S. N. Tolstov, Yu. V. Prokhorova, E. I. Uzuyeva, М. А. Khamurzova

Subjects: Get full text

Prognostic Significance of Nutritional Scores in Patients With Heart Failure: Insights From the PARAGON‐HF Trial by Henri Lu, Brian L. Claggett, Masatoshi Minamisawa, John W. Ostrominski, Alberto Foà, Maria A. Pabón, Arzu Kalayci, Muthiah Vaduganathan, Maja Cikes, Amil M. Shah, Akshay S. Desai, John J. V. McMurray, Pardeep S. Jhund, Milton Packer, Martin Lefkowitz, Jean L. Rouleau, Michael R. Zile, Faiez Zannad, Sheila M. Hegde, Scott D. Solomon, Hicham Skali

Subjects: Get full text

Effects of fluvastatin, valsartan, and their combination on endothelial function in patients with arterial hypertension and dyslipidemia by T. Sh. Mirilashvili, S. V. Villewalde, Yu. V. Kotovskaya, Zh. D. Kobalava

Subjects: Get full text

EFFICACY OF FIXED COMBINATION OF VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE IN COMPLEX THERAPY OF THE PATIENT OF VERY HIGH CARDIOVASCULAR RISK by I. M. Sokolov, N. A. Zheleznyakova

Subjects: Get full text